Res Vestib Sci.
2024 Dec;23(4):115-123. 10.21790/rvs.2024.018.
Digital therapeutics and telemedicine for benign paroxysmal positional vertigo and other vestibular disorders: a review
- Affiliations
-
- 1Dizziness Center, Department of Neurology and Clinical Neuroscience Center, Seoul National University Bundang Hospital, Seongnam, Korea
- 2Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Korea
- 3Department of Neurology, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2563706
- DOI: http://doi.org/10.21790/rvs.2024.018
Abstract
- In the recent wave of digital transformation, digital therapeutics and telemedicine are changing the concepts in the management of benign paroxysmal positional vertigo and other vestibular disorders. These technologies provide accessible and cost-effective solutions amid the ongoing digital revolution in healthcare. This review article covers the recently advanced digital therapeutics for vestibular disorders that include questionnaire- or artificial intelligence-based diagnostic algorithms, telemedicine and self-application of canalith repositioning therapy, wearable devices for monitoring of eye movements during the attacks of dizziness/vertigo, and metaverse for vestibular rehabilitation. Integration of these digital technologies would improve diagnostic accuracy and treatment efficacy, reduce the economic burden associated with vestibular disorders, and promise a revolutionary shift in patient care towards personalized medicine.
